Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK1 | P28482 | 2/20 | 0.46 |
| ▸ | NPC1 | O15118 | 1/20 | 0.46 |
| ▸ | HPGD | P15428 | 1/20 | 0.46 |
| ▸ | HTT | P42858 | 1/20 | 0.46 |
| ▸ | RAB9A | P51151 | 1/20 | 0.46 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.46 |
| ▸ | TYR | P14679 | 2/20 | 0.43 |
| ▸ | CFTR | P13569 | 4/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | PKM | P14618 | 1/20 | 0.39 |
| ▸ | ESR1 | P03372 | 1/20 | 0.37 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.37 |
| ▸ | IGF1R | P08069 | 1/20 | 0.37 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.37 |
| ▸ | CA1 | P00915 | 1/20 | 0.36 |
| ▸ | CA2 | P00918 | 1/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.35 |
| ▸ | AR | P10275 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2168406 | 0.93 | TYR (0.53) | HTTTYRKDM4EESR1ALOX15 | |
| SCHEMBL875815 | 0.90 | CNR1 (0.38) | MAPK1NPC1HPGDHTTRAB9A | |
| SCHEMBL7950540 | 0.84 | TYR (0.53) | MAPK1NPC1HPGDHTTRAB9A | |
| SCHEMBL664026 | 0.82 | CYP3A4 (0.39) | MAPK1HPGDKDM4EESR1ESR2 | |
| SCHEMBL30026986 | 0.81 | HPGD (0.58) | MAPK1NPC1HPGDHTTRAB9A | |
| SCHEMBL710654 | 0.81 | HPGD (0.58) | MAPK1NPC1HPGDHTTRAB9A | |
| SCHEMBL6232725 | 0.81 | HPGD (0.46) | MAPK1NPC1HPGDHTTRAB9A | |
| SCHEMBL30945773 | 0.80 | HPGD (0.48) | MAPK1NPC1HPGDHTTRAB9A | |
| SCHEMBL983815 | 0.80 | HPGD (0.48) | MAPK1NPC1HPGDHTTRAB9A | |
| SCHEMBL10636865 | 0.79 | TYR (0.46) | MAPK1NPC1HPGDHTTRAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 85 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3528776-B1 | REDUCED-ETHANOL MOUTH RINSE FORMULATIONS | KENVUE BRANDS LLC (US) | 2025-11-26 | — | — | EP | disclosed |
| EP-3653303-B1 | PIPETTE TIP RACK | BIOTIX INC (US) | 2025-02-26 | — | — | EP | disclosed |
| US-12201987-B2 | Pipette tip rack | BIOTIX, INC. (US) | 2025-01-21 | — | — | US | disclosed |
| US-11857653-B2 | Method of providing an oral care benefit using a poorly-soluble calcium compound and fluoride | JOHNSON & JOHNSON CONSUMER INC. (US) | 2024-01-02 | — | — | US | disclosed |
| US-11648186-B2 | Coated particles and their uses | JOHNSON & JOHNSON CONSUMER INC. (US) | 2023-05-16 | — | — | US | disclosed |
| US-11590490-B2 | Pipette tips | BIOTIX, INC. (US) | 2023-02-28 | — | — | US | disclosed |
| US-20220331222-A1 | Method of Providing Oral Care Benefits | KENVUE BRANDS LLC | 2022-10-20 | — | — | US | disclosed |
| US-20220226205-A1 | Coated Particles and Their Uses | KENVUE BRANDS LLC | 2022-07-21 | — | — | US | disclosed |
| US-11351103-B2 | Method of providing oral care benefits | JOHNSON & JOHNSON CONSUMER INC. (US) | 2022-06-07 | — | — | US | disclosed |
| US-11291613-B2 | Coated particles and their uses | JOHNSON & JOHNSON CONSUMER INC. (US) | 2022-04-05 | — | — | US | disclosed |
| US-5686064-A | MIXTURE INCLUDES TETRAALKALI METAL POLYPHOSPHATE AND TRICLOSAN; DENTIFRICES | COLGATE PALMOLIVE COMPANY (US) | 1997-11-11 | — | — | US | disclosed |
| US-5681548-A | CONTAINING AMPHOTERIC SURFACTANT AND MICROBIOCIDE | COLGATE PALMOLIVE COMPANY (US) | 1997-10-28 | — | — | US | disclosed |
| US-5599526-A | HAVING ANIONIC SURFACTANT CONTAINING A POLYOXYETHYLE ALCOHOL SULFATE AND/OR ALKALI LAURYL SULFATE, OR MIXTURE OF ALKALI LAURYL SULFATE AND AN N-ACYL-N-ALKYLTAURATE; NONCRYSTALLIZING AT LOW TEMPERTURES | COLGATE-PALMOLIVE COMPANY | 1997-02-04 | — | — | US | disclosed |
| US-5575652-A | Process for applying antibacterial oral composition to dental implant areas | COLGATE PALMOLIVE COMPANY (US) | 1996-11-19 | — | — | US | disclosed |
| US-5538715-A | DENTIFRICES WITH ANTIPLAQUE AGENTS FOR MOUTHS WITH HUMECTANTS, SILICA POLISHES AND BACTERICIDES | COLGATE PALMOLIVE COMPANY (US) | 1996-07-23 | — | — | US | disclosed |
| US-5288480-A | Antiplaque antibacterial oral composition | COLGATE-PALMOLIVE CO. (US) | 1994-02-22 | — | — | US | disclosed |
| US-5192530-A | Solubilizer, enhancing agent to aid retention, and delivery enhancement | COLGATE-PALMOLIVE COMPANY (US) | 1993-03-09 | — | — | US | disclosed |
| US-5178851-A | Dentifrices treatment with triclosan and carriers | COLGATE-PALMOLIVE COMPANY (US) | 1993-01-12 | — | — | US | disclosed |
| US-5080887-A | Polyphosphate, bactericide | COLGATE-PALMOLIVE COMPANY (US) | 1992-01-14 | — | — | US | disclosed |
| US-4894220-A | WATER AND ALCOHOL SOLVENTS, GLYCOL DERIVATIVES AND ESTERS SOLUTIONS | COLGATE-PALMOLIVE COMPANY (US) | 1990-01-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11291613-B2 | Coated particles and their uses | CD63, EPCAM, CD44 | MAPK1 4711/4885NPC1 2820/4885HPGD 3992/4885 |
| US-11648186-B2 | Coated particles and their uses | CD63, EPCAM, CD44 | MAPK1 4711/4885NPC1 2820/4885HPGD 3992/4885 |
| US-20220226205-A1 | Coated Particles and Their Uses | CD63, EPCAM, CD44 | MAPK1 4711/4885NPC1 2820/4885HPGD 3992/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.